Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q2 2025

Top Holdings431 positions

Checking export access…
Activity:

MICROSOFT CORP

71.8M$35.7B7.1%$117.27+320.00%
27 qtrssince 2018-Q4
Decreased
0

BROADCOM INC

91.5M$25.2B5.1%$29.59+823.17%
27 qtrssince 2018-Q4
Increased
63

FACEBOOK INC-CLASS A

32.5M$24B4.8%$261.64+180.96%
27 qtrssince 2018-Q4
Decreased
0

NVIDIA CORP

142.5M$22.5B4.5%$91.15+72.91%
11 qtrssince 2022-Q4
Increased
80

AMAZON.COM INC

84.7M$18.6B3.7%$115.42+90.08%
27 qtrssince 2018-Q4
Decreased
0

ELI LILLY & CO

20.8M$16.2B3.2%$636.97+21.35%
13 qtrssince 2022-Q2
Increased
75

UBER TECHNOLOGIES INC

120.3M$11.2B2.2%$60.87+50.37%
8 qtrssince 2023-Q3
Increased
55

RAYTHEON TECHNOLOGIES CORP

75.4M$11B2.2%$71.29+100.95%
22 qtrssince 2020-Q1
Decreased
0

APPLE INC

41.7M$8.6B1.7%$174.17+17.23%
27 qtrssince 2018-Q4
Decreased
0

ROYAL CARIBBEAN CRUISES LTD

25.9M$8.1B1.6%$78.82+290.13%
22 qtrssince 2020-Q1
Increased
56

GENERAL ELECTRIC CO

30.2M$7.8B1.6%$56.17+354.60%
16 qtrssince 2021-Q3
Decreased
0

ALPHABET INC-CL A

43.9M$7.7B1.5%$105.41+66.60%
27 qtrssince 2018-Q4
Decreased
0

PHILIP MORRIS INTERNATIONAL

40.6M$7.4B1.5%$59.25+194.11%
27 qtrssince 2018-Q4
Decreased
0

BOEING CO/THE

34.7M$7.3B1.5%$192.37+8.92%
11 qtrssince 2022-Q4
Decreased
0

VERTEX PHARMACEUTICALS INC

16.1M$7.2B1.4%$430.59+3.39%
10 qtrssince 2023-Q1
Increased
56

STARBUCKS CORP

76.7M$7B1.4%$90.89-2.34%
19 qtrssince 2020-Q4
Increased
81

JPMORGAN CHASE & CO

23.5M$6.8B1.4%$155.31+82.29%
27 qtrssince 2018-Q4
Increased
55

NETFLIX INC

4.7M$6.3B1.3%$33.58+298.76%
27 qtrssince 2018-Q4
Increased
53

ABBOTT LABORATORIES

41.8M$5.7B1.1%$68.16+94.16%
27 qtrssince 2018-Q4
Decreased
0

CARRIER GLOBAL CORP

75.2M$5.5B1.1%$36.42+97.31%
21 qtrssince 2020-Q2
Decreased
0
$499.5B
AUM
431
Positions
Q2 2025
Filing
HI score · 4.0/5
Quarterly 13F Value Change
+9%Q1'24$442B+3%Q2'24$455.7B+6%Q3'24$481.1B+1%Q4'24$486.4B-5%Q1'25$459.9B+9%Q2'25$499.5B
Activity profile
$ moved · Q2'25
New2%Increased49%Decreased46%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.9 years
<1Q6%1-4Q15%1-2Y11%2Y+68%

Capital Research Global Investors manages $499.5B across 431 positions as of Q2 2025. Top holdings: MSFT (7.1%), AVGO (5.1%), META (4.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q2 2025 Summary

Active quarter - 31 new positions, 56 exits, 214 increased. Top move: SBUX (INCREASED, conviction 81). Portfolio: $499.5B across 431 positions.

Top holdings by portfolio weight

Total AUM$499B
MSFT7.15%
AVGO5.05%
META4.80%
NVDA4.51%
AMZN3.72%
LLY3.24%
UBER2.25%
RTX2.20%
AAPL1.71%
RCL1.62%
Other1.56%

Portfolio allocation by GICS sector

Sectors11
Technology28.64%
Consumer Cyclical13.59%
Healthcare12.73%
Industrials11.44%
Financial Services9.96%
Communication Services9.48%
Consumer Defensive3.76%
Energy3.49%
Basic Materials2.97%
Utilities2.37%
Other1.57%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Consumer Cyclical, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOAltria Group Inc
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAmerican Electric Power Co Inc
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corp
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used